SLC5A2 and chronic kidney disease: Moreover, SGLT-2 administration is correlated with renal protective effects; it is known that in patients with DM, CKD is highly prevalent mostly because of the association of hyper-glycemia, dyslipidaemia and high blood pressure [83].